Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07876505
PHASE1

Healthy Adult Participants Trial Comparing Different Cenvacibart Presentations

Sponsor: Regeneron Pharmaceuticals

View on ClinicalTrials.gov

Summary

This trial is being done in non-obese healthy participants to compare two different forms of cenvacibart. The main goal of the trial is to learn about the trial medicine and how it is absorbed, modified, and removed from the body. The trial will look at: * What side effects cenvacibart might cause and how it feels after the dose * Levels of cenvacibart in the blood at different time points * Whether the body makes proteins called antibodies against cenvacibart (which could make the trial medicine less effective or could lead to side effects) * What happens when cenvacibart travels through the body

Official title: A Phase 1, Randomized, Open-Label, Single-Dose Trial to Compare the Pharmacokinetics, Safety, and Tolerability of Different Cenvacibart (REGN7508) Presentations in Healthy Participants

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2026-11-23

Completion Date

2027-05-14

Last Updated

2026-10-15

Healthy Volunteers

Yes

Interventions

DRUG

Cenvacibart

Administered per the protocol